{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T14:14:15Z","timestamp":1777731255961,"version":"3.51.4"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.ejps.2017.09.022","type":"journal-article","created":{"date-parts":[[2017,9,14]],"date-time":"2017-09-14T21:32:05Z","timestamp":1505424725000},"page":"638-649","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["A parenteral docetaxel-loaded lipid microsphere with decreased 7-epidocetaxel conversion in vitro and in vivo"],"prefix":"10.1016","volume":"109","author":[{"given":"Lifeng","family":"Luo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiuzhi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiuyue","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linlin","family":"Miao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuezhi","family":"Zhuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiawen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haibing","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tian","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xing","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2017.09.022_bb0005","unstructured":"AG, S., 2008. Pharmaceutical composition of improved stability containing taxane derivatives. EP."},{"key":"10.1016\/j.ejps.2017.09.022_bb0010","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1124\/dmd.30.11.1149","article-title":"Docetaxel (Taxotere) is not metabolized by recombinant human CYP1B1 in vitro, but acts as an effector of this isozyme","volume":"30","author":"Bournique","year":"2002","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejps.2017.09.022_bb0015","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1002\/ejlt.201400278","article-title":"Formulation and preparation of a stable intravenous disulfiram-loaded lipid emulsion","volume":"117","author":"Chen","year":"2015","journal-title":"Eur. J. Lipid Sci. Technol."},{"key":"10.1016\/j.ejps.2017.09.022_bb0020","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2165\/00003088-199936020-00002","article-title":"Clinical pharmacokinetics of docetaxel","volume":"36","author":"Clarke","year":"1999","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejps.2017.09.022_bb0025","doi-asserted-by":"crossref","first-page":"483","DOI":"10.5414\/CPP48483","article-title":"Evidence for the conversion of docetaxel into 7\u2032-epidocetaxel in patients receiving Taxotere-based conventional chemotherapy","volume":"48","author":"Czejka","year":"2010","journal-title":"Int. J. Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejps.2017.09.022_bb0030","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.ajps.2016.04.002","article-title":"An intravenous clarithromycin lipid emulsion with a high drug loading, H-bonding and a hydrogen-bonded ion pair complex exhibiting excellent antibacterial activity","volume":"11","author":"Gong","year":"2016","journal-title":"Asian J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2017.09.022_bb0035","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0959-8049(97)00351-1","article-title":"In vitro modulation of doxorubicin and docetaxel antitumoral activity by methyl-beta-cyclodextrin","volume":"34","author":"Grosse","year":"1998","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ejps.2017.09.022_bb0040","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1080\/01932698508943947","article-title":"The presence of liposomal material in phosphatide stabilized emulsions","author":"Groves","year":"1985","journal-title":"J. Dispers. Sci. Technol."},{"key":"10.1016\/j.ejps.2017.09.022_bb0045","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jconrel.2015.12.016","article-title":"Drug delivery and drug targeting with parenteral lipid nanoemulsions - a review","volume":"223","author":"H\u00f6rmann","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejps.2017.09.022_bb0050","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/0165-6147(92)90048-B","article-title":"Mechanism of action of taxol","volume":"13","author":"Horwitz","year":"1992","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejps.2017.09.022_bb0055","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jconrel.2008.02.003","article-title":"Tumor targetability and antitumor effect of docetaxel-loaded hydrophobically modified glycol chitosan nanoparticles","volume":"128","author":"Hwang","year":"2008","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejps.2017.09.022_bb0060","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0168-3659(03)00271-2","article-title":"Preparation, characterization, cytotoxicity and pharmacokinetics of liposomes containing docetaxel","volume":"91","author":"Immordino","year":"2003","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejps.2017.09.022_bb0065","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0378-5173(97)00369-4","article-title":"The effect of oil components and homogenization conditions on the physicochemical properties and stability of parenteral fat emulsions","volume":"163","author":"Jumaa","year":"1998","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2017.09.022_bb0070","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0169-409X(00)00102-2","article-title":"Disposition characteristics of emulsions and incorporated drugs after systemic or local injection","volume":"45","author":"Kawakami","year":"2000","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejps.2017.09.022_bb0075","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S1773-2247(11)50006-1","article-title":"Lecithin-based nanoemulsions","volume":"21","author":"Klang","year":"2011","journal-title":"J. Drug Delivery Sci. Technol."},{"key":"10.1016\/j.ejps.2017.09.022_bb0080","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/0005-2760(70)90046-9","article-title":"The detection of oxidation in liposome preparations","volume":"210","author":"Klein","year":"1970","journal-title":"Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism"},{"key":"10.1016\/j.ejps.2017.09.022_bb0085","first-page":"3","article-title":"Preclinical evaluation of docetaxel (Taxotere)","author":"Lavelle","year":"1995","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.ejps.2017.09.022_bb0090","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1211\/jpp.61.11.0007","article-title":"Preparation and pharmacokinetics of docetaxel based on nanostructured lipid carriers","volume":"61","author":"Li","year":"2009","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejps.2017.09.022_bb0095","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.ejpb.2008.01.015","article-title":"The antitumor effect of novel docetaxel-loaded thermosensitive micelles","volume":"69","author":"Liu","year":"2008","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejps.2017.09.022_bb0100","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ijpharm.2007.06.003","article-title":"Formulation and thermal sterile stability of a less painful intravenous clarithromycin emulsion containing vitamin E","volume":"346","author":"Lu","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2017.09.022_bb0105","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.ijpharm.2014.07.047","article-title":"A highly stable norcantharidin loaded lipid microspheres: preparation, biodistribution and targeting evaluation","volume":"473","author":"Ma","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2017.09.022_bb0110","unstructured":"Machado, A., Maranduba, A., Guimar\u00e3es, E., Machado, L., Santiago Junior, M., Silva, M., 2008. Pharmaceutical compositions containing docetaxel and a degradation inhibitor and a process for obtaining the same. US."},{"key":"10.1016\/j.ejps.2017.09.022_bb0115","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1002\/j.1875-9114.1998.tb03939.x","article-title":"Case-control study of amphotericin B in a triglyceride fat emulsion versus conventional amphotericin B in patients with AIDS","volume":"18","author":"Manfredi","year":"1998","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ejps.2017.09.022_bb0120","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1007\/s11095-013-1093-5","article-title":"Is an alternative drug delivery system needed for docetaxel? The role of controlling epimerization in formulations and beyond","volume":"30","author":"Manjappa","year":"2013","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2017.09.022_bb0125","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0022-3565(25)39137-8","article-title":"Taxol is converted to 7-epitaxol, a biologically active isomer, in cell culture medium","volume":"242","author":"Ringel","year":"1987","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejps.2017.09.022_bb0130","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1093\/jnci\/83.4.288","article-title":"Studies with RP 56976 (taxotere): a semisynthetic analogue of taxol","volume":"83","author":"Ringel","year":"1991","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ejps.2017.09.022_bb0135","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.ijpharm.2014.06.024","article-title":"A continuous flow method for estimation of drug release rates from emulsion formulations","volume":"472","author":"Salmela","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2017.09.022_bb0140","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ijpharm.2009.02.006","article-title":"Formulation, stability and degradation kinetics of intravenous cinnarizine lipid emulsion","volume":"373","author":"Shi","year":"2009","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2017.09.022_bb0145","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/00008571-199810000-00004","article-title":"Role of human cytochrome P450 3A4 and 3A5 in the metabolism of taxotere and its derivatives: enzyme specificity, interindividual distribution and metabolic contribution in human liver","volume":"8","author":"Shou","year":"1998","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.ejps.2017.09.022_bb0150","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1054\/clnu.2000.0370","article-title":"Long-chain versus medium-chain lipids in acute pancreatitis complicated by acute respiratory distress syndrome: effects on pulmonary hemodynamics and gas exchange","volume":"20","author":"Smyrniotis","year":"2001","journal-title":"Clin. Nutr."},{"key":"10.1016\/j.ejps.2017.09.022_bb0155","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S0090-9556(25)07385-4","article-title":"Isolation, purification and biological activity of major docetaxel metabolites from human feces","volume":"24","author":"Sparreboom","year":"1996","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejps.2017.09.022_bb0160","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ijpharm.2013.10.039","article-title":"Parenteral formulation of larotaxel lipid microsphere tackling poor solubility and chemical instability","volume":"460","author":"Teng","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2017.09.022_bb0165","doi-asserted-by":"crossref","first-page":"665","DOI":"10.2165\/00003088-200342070-00005","article-title":"Pharmacological effects of formulation vehicles: implications for cancer chemotherapy","volume":"42","author":"ten Tije","year":"2003","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejps.2017.09.022_bb0170","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.jpba.2005.10.037","article-title":"Isolation and characterization of impurities in docetaxel","volume":"40","author":"Vasu","year":"2006","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.ejps.2017.09.022_bb0175","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jconrel.2006.07.023","article-title":"Submicron lipid emulsion as a drug delivery system for nalbuphine and its prodrugs","volume":"115","author":"Wang","year":"2006","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejps.2017.09.022_bb0180","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.biomaterials.2008.09.014","article-title":"The performance of docetaxel-loaded solid lipid nanoparticles targeted to hepatocellular carcinoma","volume":"30","author":"Xu","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejps.2017.09.022_bb0185","doi-asserted-by":"crossref","first-page":"618","DOI":"10.3136\/nskkk1962.30.618","article-title":"Stability of emulsion prepared with soybean phospholipids and transfer of phospholipid to separated phases","volume":"30","author":"Yamano","year":"1983","journal-title":"Nippon Shokuhin Kogyo Gakkaishi"},{"key":"10.1016\/j.ejps.2017.09.022_bb0190","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1080\/17425247.2016.1213235","article-title":"Evaluating the safety of phytosterols removed perilla seed oil-based lipid emulsion","volume":"13","author":"Yang","year":"2016","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ejps.2017.09.022_bb0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejps.2013.09.024","article-title":"Improving cabazitaxel chemical stability in parenteral lipid emulsions using cholesterol","volume":"52","author":"Yanjie","year":"2014","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2017.09.022_bb0200","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1007\/s11095-010-0180-0","article-title":"Evaluation of docetaxel-loaded intravenous lipid emulsion: pharmacokinetics, tissue distribution, antitumor activity, safety and toxicity","volume":"27","author":"Zhao","year":"2010","journal-title":"Pharm. Res."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098717305146?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098717305146?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T19:13:00Z","timestamp":1750878780000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098717305146"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":40,"alternative-id":["S0928098717305146"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2017.09.022","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A parenteral docetaxel-loaded lipid microsphere with decreased 7-epidocetaxel conversion in vitro and in vivo","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2017.09.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}